World Leading Electronics Contract Manufacturer Buys Another Isis(R) System From ART

Saint-Laurent,Quebec

ART Advanced Research

Technologies Inc. (ART) (TSE "ARA"), a leading developer of optical and

infrared imaging technologies for the detection of anomalies in the medical

sector and the electronics industry is pleased to announce the repeat sale of

its ISIS(R) 2020 model, a semi-automatic infrared inspection system to a world-

leading electronics contract manufacturer.

"This sale to one of the major electronics contract manufacturers is an

acknowledgement of the effectiveness and efficiency of ART's innovative

ISIS(R) systems based on infrared verification imaging technology" states

Serge Huot, President and CEO of ART. "This is the third sale to our repeat

contract manufacturer client and we are optimistic that as economic activity

continues to increase, so will our sales of ISIS(R) systems". The recognition

by key players in both the medical sector and electronics industry of the

promise which our innovative optical imaging technology holds will facilitate

the consolidation of our cash position.

ABOUT ISIS(R)

The ISIS(R) infrared (IR) verification system provides an innovative,

fast, and cost effective end-of-line screening, and off-line inspection and

failure analysis tool to help manufacturers achieve the next level of process

improvement in the electronics printed circuit board assembly (PCBA) industry.

ISIS(R) does this by exploiting infrared imaging technology to find problems

with powered PCBA's. Use of IR technology provides ISIS(R) with a broad fault

coverage capability so that quality problems can be quickly identified and

resolved. ISIS(R) is available both in a semi-automatic version, the 2020

model, designed for off-line IR verification, and in an automated version, the

7070 model, designed for in-line IR verification.

ABOUT ART

ART Advanced Research Technologies Inc. is a North American company that

is involved in the research, design, development, and marketing of optical and

infrared imaging technologies used in the detection of anomalies in the

medical sector and the electronics industry. ART is in the process of bringing

to market an optical imaging device to detect and diagnose breast cancer. The

device, known as SoftScan(R), represents an innovative imaging solution for

the detection of breast cancer without the adverse consequences associated

with traditional technology. SoftScan(R) uses the time domain technique in

optical imaging, which generates the most information possible about tissue.

ART is also currently commercializing its ISIS(R) products, which are based on

infrared verification imaging technology, and are used to detect defects in

printed circuit board assemblies. ART has been listed on the Toronto Stock

Exchange since June 29, 2000 (TSE: "ARA").